SAN MATEO, Calif.–(BUSINESS WIRE)–Sumeru Equity Partners (SEP), a growth-focused technology investment firm, today announced the initial public offering (IPO) of Locaweb Servicos de Internet SA (BVMF:LWSA3), a portfolio company of […]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Beam Therapeutics Inc. (Nasdaq:BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the closing of its initial public offering of 12,176,471 shares of common […]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the pricing of its initial public offering of 10,588,236 shares of […]

NEW YORK–(BUSINESS WIRE)–Schrödinger, Inc. (the “Company”) (Nasdaq: SDGR), whose differentiated, physics-based software platform enables discovery of high-quality, novel molecules for drug development and materials applications, today announced the closing of […]

Pure-play critical digital infrastructure provider to trade under the ticker symbol VRT COLUMBUS, Ohio–(BUSINESS WIRE)–Vertiv Holdings Co, a global provider of critical digital infrastructure and continuity solutions, today announced the […]

CORAL GABLES, Fla.–(BUSINESS WIRE)–Professional Holding Corp. (the “Company”), a financial holding company that operates through its wholly owned subsidiary, Professional Bank, announced today the pricing of its initial public offering […]

BUFORD, Ga.–(BUSINESS WIRE)–OneWater Marine Inc. (NASDAQ: ONEW) (“OneWater”) announced today the pricing of an initial public offering of 4,615,385 shares of its Class A common stock at $12.00 per share. […]

2019 marked the re-birth of SPACs on NEO TORONTO–(BUSINESS WIRE)–NEO is pleased to announce that in 2019, the Neo Exchange Inc. (“NEO Exchange” or “NEO”) facilitated over CAD $1.5 billion […]

NEW YORK–(BUSINESS WIRE)–Schrödinger, Inc. (the “Company”) (Nasdaq: SDGR), whose differentiated, physics-based software platform enables discovery of high-quality, novel molecules for drug development and materials applications, today announced the pricing of […]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the pricing of its initial public offering of 10,588,236 shares of […]